Mackenzie Financial Corp Gilead Sciences, Inc. Transaction History

Mackenzie Financial Corp

$66.8 Billion
Q3 2024

A detailed history of Mackenzie Financial Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 606,230 shares of GILD stock, worth $53.6 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

606,230

Previous 619,002 2.06%

Holding current value

$53.6 Million

Previous $42.5 Million 19.65%

% of portfolio

0.08%

Previous 0.07%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $850,487 - $1.07 Million	-12,772 Reduced 2.06%	606,230 $50.8 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $4.88 Million - $5.64 Million	77,337 Added 14.28%	619,002 $42.5 Million
Q1 2024 May 10, 2024	BUY	$71.58 - $87.29 $437,210 - $533,167	6,108 Added 1.14%	541,665 $39.7 Million
Q4 2023 Jan 30, 2024	BUY	$73.27 - $83.09 $3.2 Million - $3.63 Million	43,630 Added 8.87%	535,557 $43.4 Million
Q3 2023 Oct 25, 2023	BUY	$73.94 - $80.67 $967,874 - $1.06 Million	13,090 Added 2.73%	491,927 $36.9 Million
Q2 2023 Aug 03, 2023	BUY	$76.01 - $86.7 $5.68 Million - $6.48 Million	74,710 Added 18.49%	478,837 $36.9 Million
Q1 2023 Apr 24, 2023	SELL	$77.31 - $88.08 $5.95 Million - $6.78 Million	-77,024 Reduced 16.01%	404,127 $33.5 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $7.28 Million - $10.5 Million	-116,844 Reduced 19.54%	481,151 $41.3 Million
Q3 2022 Oct 07, 2022	BUY	$59.54 - $68.01 $521,629 - $595,835	8,761 Added 1.49%	597,995 $36.9 Million
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $1.54 Million - $1.73 Million	26,673 Added 4.74%	589,234 $36.4 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $1.87 Million - $2.35 Million	32,327 Added 6.1%	562,561 $33.4 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $1.49 Million - $1.7 Million	23,035 Added 4.54%	530,234 $38.5 Million
Q3 2021 Nov 08, 2021	BUY	$67.69 - $73.03 $4.82 Million - $5.2 Million	71,189 Added 16.33%	507,199 $35.4 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $1.4 Million - $1.53 Million	22,080 Added 5.33%	436,010 $30 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $12.9 Million - $14.8 Million	215,664 Added 108.78%	413,930 $26.8 Million
Q4 2020 Feb 10, 2021	BUY	$56.65 - $64.55 $3.7 Million - $4.21 Million	65,296 Added 49.11%	198,266 $11.6 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $3.67 Million - $4.61 Million	-59,026 Reduced 30.74%	132,970 $8.4 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $1.22 Million - $1.41 Million	16,800 Added 9.59%	191,996 $14.8 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $13.4 Million - $17.1 Million	-213,223 Reduced 54.9%	175,196 $13.1 Million
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $5.43 Million - $5.97 Million	-88,055 Reduced 18.48%	388,419 $25.2 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $16.9 Million - $18.6 Million	269,974 Added 130.74%	476,474 $30.2 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $14.8 Million - $16.6 Million	-239,441 Reduced 53.69%	206,500 $14 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $5.09 Million - $5.71 Million	-81,447 Reduced 15.44%	445,941 $29 Million
Q4 2018 Feb 06, 2019	SELL	$60.54 - $79.0 $5.95 Million - $7.77 Million	-98,354 Reduced 15.72%	527,388 $33 Million
Q3 2018 Nov 15, 2018	SELL	$71.28 - $78.92 $8.68 Million - $9.61 Million	-121,729 Reduced 16.29%	625,742 $48.3 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $13.2 Million - $15.4 Million	203,371 Added 37.38%	747,471 $53 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $15.5 Million - $18.9 Million	-213,308 Reduced 28.16%	544,100 $41 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $22.2 Million - $26.1 Million	312,671 Added 70.3%	757,408 $54.3 Million
Q3 2017 Nov 13, 2017	SELL	$72.11 - $85.47 $287,502 - $340,768	-3,987 Reduced 0.89%	444,737 $36 Million
Q2 2017 Aug 14, 2017	BUY	N/A	448,724	448,724 $31.8 Million

Others Institutions Holding GILD

# of Institutions

1,917

Shares Held

995M

Call Options Held

10.1M

Put Options Held

9.46M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Gilead Sciences, Inc. Transaction History